Research and Markets: Industry Dynamics: Guide to the Asia-Pacific Life Sciences Industry

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/dc3c8a/industry_dynamics) has announced the addition of the "Industry Dynamics: 2010 Guide to the Asia-Pacific Life Sciences Industry" report to their offering.

“Industry Dynamics: 2010 Guide to the Asia-Pacific Life Sciences Industry”

Pharmaceutical companies are expanding into the Asia-Pacific region to increase their market share and reduce costs. The life sciences industry is difficult enough for technology vendors to enter, but add to it the complexity of emerging markets, and the process can be downright overwhelming. Ovum provides an introduction to the life sciences in APAC in order for vendors to penetrate the market.

Features and benefits

• Offers an overview of the pharmaceutical and biotechnology sectors in Australia, China, India, and Japan
• Discusses key areas where there is greatest need for technology in the APAC life sciences industry
• Provides go-to-market strategies to help vendors enter the APAC pharma and biotech markets and realize successful

Highlights

Before attempting to penetrate the APAC pharma market, it is important to understand the complexity of the global life sciences industry. Once vendors understand the industry as a whole, they will better comprehend the dynamics of the APAC markets and how the developed and emerging pharma industries fit into their customers' global strategies.

The Asia-Pacific life sciences industry varies greatly, comprised of both developed and emerging markets. It is also home to small, emerging biotech companies with up to ten employees as well as Big Pharma with thousands of employees. As wide as the spectrum is for size and type of life sciences company, so is the need for IT solutions.

The emerging markets have seen tremendous growth, and this trend will likely continue, but not without the help of key IT solutions. The APAC pharma and biotech sectors are much more open to the use of IT that their Western counterparts, but it is still important for technology vendors to understand where and how to best realize success.

Your key questions answered

• Understand the pharmaceutical and biotechnology product lifecycle and business processes
• Identify emerging areas of concern for pharmaceutical and biotechnology companies, particularly in Australia, China, India and Japan
• Gain insight into what solutions and services will appeal most to APAC life sciences companies

KEY MESSAGES

• Understanding the Pharma Process
• About the industry
• The drug discovery and development process is long and expensive
• The biggest challenge facing the pharma industry is the successful navigation of the 2011 patent cliff
• The APAC Life Sciences Market
• Overview of APAC markets
• Australia's pharmaceutical market
• China's pharmaceutical market
• India's pharmaceutical market
• Japan's pharmaceutical market
• Slowing growth in major developed markets drives pharma M&A in APAC
• Trends within countries based on the process areas
• Opportunities for Technology Vendors
• How best to capitalize
• The pharma product lifecycle plays a crucial role in IT strategy
• IT engagement with pharma comes with its own set of dynamics
• With no two life sciences markets exactly the same, neither is their IT investment
• Recommendations for Technology Vendors
• The right solutions for the right processes
• Position technology along the pharma lifecycle
• Know the pharma company's product pipeline and drug portfolio
• Route to market will be a critical success factor
• Keep in mind that IT budget allocation does not equal priority
• Focus on IT solutions that enable the shift towards biotech research

For more information visit http://www.researchandmarkets.com/research/dc3c8a/industry_dynamics

Source: Ovum